Diabetes Board decisions

The Board has decided to remand the case due to conflicting evidence regarding the type of diabetes mellitus and a need for additional medical records.

The Veteran's disability ratings for diabetic peripheral neuropathy of the right and left lower extremities were reduced, but this decision reinstates the original ratings.

The Veteran's claim for an effective date earlier than January 10, 2019 for peripheral neuropathy of the right lower extremity was denied.,The Veteran's claim for a rating higher than 70 percent for PTSD was denied.

The Board has granted service connection for hypertension, COPD, diabetes mellitus type II, diabetic neuropathy of the bilateral upper extremities, OSA, left and right below knee amputations, bilateral lower extremity scars, and CAD as secondary to the Veteran's service-connected diabetes mellitus type II.

The Board denied the Veteran's claims for service connection for diabetes mellitus, finding no causal relationship between his current disability and active duty service or a service-connected condition. The claim was also not granted on a secondary basis due to hypertension.

The Board has denied service connection for coronary artery disease, diabetes mellitus, and erectile dysfunction. The claim of service connection for back disability was dismissed as untimely.

The Veteran's hearing loss and diabetes mellitus, type II are not service-connected. The claim for a higher evaluation for diabetes mellitus is denied. The Veteran's rhinitis is currently rated as noncompensable but granted an initial evaluation of 10 percent.

The Veteran's TDIU and combined disability ratings have satisfied the criteria for special monthly compensation based on statutory housebound status since September 18, 2018.

The Board denied service connection for hypertensive vascular disease, concussion, diabetes mellitus, seizure disability, bilateral pes planus, and an acquired psychiatric disorder (alcohol use disorder in sustained remission and PTSD). The effective date for hypertension was denied as the Veteran's claim was received within one year of the PACT Act.

The Veteran's TDIU was granted effective June 15, 2022, based on his service-connected disabilities. The effective date for the establishment of basic eligibility for DEA benefits is also June 15, 2022.

The Veteran's urinary frequency is due to his service-connected hypertension and diabetes, and the Board has granted service connection for this condition as secondary to those disabilities.

The Veteran's TDIU and DEA benefits were granted effective April 17, 2023. Service connection for OSA was also granted with an effective date of April 17, 2023.

The Board has remanded the claims for service connection due to inadequate VA medical opinions and a need to confirm the Veteran's exposure history. The claims will be reconsidered with new evidence.

The Board has remanded the Veteran's claim for service connection for type II diabetes mellitus, which is secondary to his service-connected hypertension and kidney disease. The case was remanded due to duty-to-assist errors.

The Veteran's claim for service connection for diabetes mellitus type II, gastroesophageal reflux disease (GERD), obstructive sleep apnea, thoracolumbar spine disability, left hip disability, and right hip disability has been granted. The rating assigned is 10 percent for chronic allergic rhinitis effective October 9, 2023.

The Veteran's appeals for earlier effective dates were dismissed as he withdrew his claims prior to the Board hearing.

The Veteran's service-connected disabilities, including PTSD, CAD, and Parkinson's disease, render him unable to secure and follow a substantially gainful employment. The Board has granted his TDIU claim.

The Board has decided to remand the case due to insufficient medical opinion regarding whether the Veteran's service-connected disabilities contributed to his death. The AOJ will obtain a new VA opinion on this matter.

The Veteran's appeal for service connection of various conditions has been dismissed without prejudice due to their death.

The Board dismissed the Veteran's appeal regarding service connection for diabetes mellitus, type II. The Veteran was granted an initial 40 percent rating for BPH associated with PTSD and a 30 percent rating for dermatitis from October 23, 2025 onwards. Other issues were either denied or remanded.